The Dutch 'Folic Acid Campaign' - Have the goals been achieved?

Paediatric and Perinatal Epidemiology

Volumn 14, Issue 2, 2000, Pages 111-117

  Van Der Pal De Bruin, K M ^a   De Walle, H E K ^d   Jeeninga, W ^b   De Rover, C ^c   Cornel, M C ^d   De Jong Van Den Berg, L T W ^e   Schouten, J ^b   Brand, R ^f   Buitendijk, S E ^a  

^a TNO   (Netherlands)

^b GGD Midden Brabant   (Netherlands)

^c GGD Achterhoek   (Netherlands)

^d Department of Medical Genetics   (Netherlands)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GENERAL PRACTITIONER; HEALTH EDUCATION; HEALTH VISITOR; HUMAN; MATERNAL CARE; MIDWIFE; NETHERLANDS; NEURAL TUBE DEFECT; NORMAL HUMAN; PRENATAL PERIOD; QUESTIONNAIRE;

ADOLESCENT; ADULT; AWARENESS; DEMOGRAPHY; FEMALE; FOLIC ACID; HUMANS; NETHERLANDS; NEURAL TUBE DEFECTS; NUTRITION POLICY; PATIENT COMPLIANCE; PRECONCEPTION CARE; PREGNANCY; PRENATAL CARE; QUESTIONNAIRES;

EID: 0034038916     PISSN: 02695022     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3016.2000.00251.x     Document Type: Article

References (22)

1. den Ouden AL, Hirasing RA, Buitendijk SE, de Jong-van den Berg LTW, de Walle HEK, Cornel MC. Prevalence, clinical outcome and prognosis of neural tube defects in the Netherlands [Prevalentie, klinisch beeld en prognose van neuralebuisdefecten in Nederland.] Nederlands Tijdschrift Voor Geneeskde 1996; 140:2092-2095.
2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131-137.
3. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. New England Journal of Medicine 1992; 327:1832-1835.
4. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993; 269:1257-1261.
5. Gezondheidsraad/Voedingsraad. Continued Advice Concerning Folic Acid Use in Relation to Neural Tube Defects. [Vervolgadvies inzake Foliumzuurvoorziening in relatie tot neuraalbuisdefecten.] Den Haag: Voorlichtingsbureau voor de Voeding, 1993.
6. Cornel MC, Erickson JD. Comparison of national policies on periconceptional use of folic acid to prevent spina bifida and anencephaly (SBA). Teratology 1997; 55:134-137.
7. Health Education Authority. Awareness, Attitudes and Behaviour Towards Folic Acid Amongst Women. A Report by the Health Education Authority. London: Health Education Authority, 1996 (ISBN 752106724).
8. Bower C, Knowles S, Nicol D. Changes in folate supplementation, and in serum and red cell folate levels in antenatal patients over the course of a health promotion project for the prevention of neural tube defects. Australia and New Zealand Journal of Obstetrics and Gynaecology 1997; 37:267-271.
9. Erickson D. Knowledge and Use of Folic Acid by Women of Childbearing Age: United States 1997. International Clearinghouse for Birth Defects Monitoring Systems, Annual Report 1997, with Data for 1995. Rome: The International Centre for Birth Defects, 1997 (ISSN 0743-5703).
10. Inspectorate of Public Health (The Netherlands). Prevention of Neural Tube Defects. Rijswijk, 1993.
11. Voorlichtingsbureau voor de Voeding. Prevention of Neural Tube Defects by Supplementation of Folic Acid. (Preventie van neuraalbuisdefecten door middel van foliumzuur [suppletie]). Praeventiefondsvoorstel, The Hague, 1994.
12. CBS. Births 1992-96. Maandstatistiek van de Bevolking Central Bureau of Statistics 1997; pp. 28-38.
13. CBS. Statistics 1998. Central Bureau of Statistics, Voorburg/ Heerlen, 1998.
14. de Jong-van den Berg LT, Cornel MC, Tymstra T, Buitendijk SE. Folate prophylaxis in pregnancy (Letter). Lancet 1995; 346:1227-1228.
15. de Jong-van den Berg L, Walle de H, van der Pal-de Bruin K, Buitendijk S, Cornel M. Increasing awareness of and behaviour towards periconceptional folic acid consumption in the Netherlands from 1994 to 1995. European Journal of Clinical Pharmacology 1998; 54:329-331.
16. Bower C, Blum L, O'Daly K, Higgens C, Loutsky F, Kosky C. Promotion of folate for the prevention of neural tube defects: knowledge and use of periconceptional folic acid supplements in Western Australia, 1992 to 1995. Australian and New Zealand Journal of Public Health 1997; 21:716-721.
17. Wild J, Sutcliffe M, Schorah CJ, Levene MI. Prevention of neural tube defects. Lancet 1997; 350:30.
18. Clark NA, Fisk NM. Minimal compliance with the Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. British Journal of Obstetrics and Gynaecology 1994; 101:709-710.
19. Sharpe G, Young G. Most pregnant women do not take folic acid. British Medical Journal 1995; 311:256.
20. Johnston RB, Staples DA. Use of folic acid containing supplements among women of childbearing age. United States 1997. MMWR Morbidity and Mortality Weekly Report 1998; 47:131-134.
21. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996; 347:657-659.
22. Czeizel AE, Merhala Z. Bread fortification with folic acid, vitamin B12 and vitamin B6 in Hungary. Lancet 1998; 352:1225.